FALZETTI, Franca
 Distribuzione geografica
Continente #
NA - Nord America 3.724
EU - Europa 2.785
AS - Asia 2.467
SA - Sud America 414
Continente sconosciuto - Info sul continente non disponibili 261
AF - Africa 68
OC - Oceania 4
Totale 9.723
Nazione #
US - Stati Uniti d'America 3.621
SG - Singapore 1.100
IT - Italia 617
IE - Irlanda 445
CN - Cina 414
BR - Brasile 322
RU - Federazione Russa 301
HK - Hong Kong 289
DE - Germania 258
VN - Vietnam 253
UA - Ucraina 246
SE - Svezia 229
FI - Finlandia 196
FR - Francia 160
GB - Regno Unito 112
KR - Corea 93
IN - India 65
BD - Bangladesh 48
TR - Turchia 44
RO - Romania 43
CA - Canada 42
MX - Messico 39
AR - Argentina 34
BE - Belgio 30
CZ - Repubblica Ceca 25
AT - Austria 23
PL - Polonia 23
IQ - Iraq 22
NL - Olanda 20
UZ - Uzbekistan 19
JP - Giappone 17
ZA - Sudafrica 16
ES - Italia 15
PK - Pakistan 15
SA - Arabia Saudita 13
CO - Colombia 12
EC - Ecuador 12
ET - Etiopia 12
LT - Lituania 11
MA - Marocco 11
CH - Svizzera 10
PH - Filippine 10
CL - Cile 9
EG - Egitto 8
ID - Indonesia 7
MY - Malesia 7
PY - Paraguay 7
AZ - Azerbaigian 6
JO - Giordania 6
LB - Libano 6
VE - Venezuela 6
GR - Grecia 5
KE - Kenya 5
OM - Oman 5
BO - Bolivia 4
GT - Guatemala 4
JM - Giamaica 4
NP - Nepal 4
QA - Qatar 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IL - Israele 3
KZ - Kazakistan 3
PE - Perù 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
DK - Danimarca 2
EU - Europa 2
HR - Croazia 2
NI - Nicaragua 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GF - Guiana Francese 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
Totale 9.454
Città #
Singapore 791
Chandler 499
Dublin 445
San Jose 318
San Mateo 299
Hong Kong 288
Perugia 271
Ashburn 249
Boardman 157
Jacksonville 138
Santa Clara 120
Ann Arbor 111
Beijing 105
Munich 101
Moscow 100
Seoul 93
Dong Ket 86
Medford 85
Princeton 83
Lauterbourg 79
Altamura 78
Los Angeles 76
New York 72
Andover 69
Helsinki 63
Turku 62
Lawrence 58
Wilmington 56
Ho Chi Minh City 55
Bucharest 40
Houston 34
Hanoi 33
Piscataway 33
Brussels 30
São Paulo 28
The Dalles 28
Foligno 27
Dallas 26
Saint Petersburg 24
Izmir 23
Council Bluffs 22
Dearborn 22
Des Moines 22
Frankfurt am Main 21
Redwood City 21
Brooklyn 20
Norwalk 20
London 19
Mexico City 18
Shanghai 18
Tokyo 17
Brno 16
Orem 16
Atlanta 15
Bologna 15
Milan 15
Warsaw 15
Denver 14
Rio de Janeiro 13
San Francisco 13
San Paolo di Civitate 13
Chennai 11
Montreal 11
Stockholm 11
Vienna 11
Addis Ababa 10
Assisi 10
Falkenstein 10
Falls Church 10
Nuremberg 10
Redmond 10
Rome 10
West Jordan 10
Woodbridge 10
Boston 9
Da Nang 9
Johannesburg 9
Tashkent 9
Auburn Hills 8
Baghdad 8
Barnet 8
Chicago 8
Groningen 8
Hefei 8
Toronto 8
Amsterdam 7
Belo Horizonte 7
Charlotte 7
Curitiba 7
Florence 7
Guangzhou 7
Hải Dương 7
Lahore 7
New Delhi 7
Olomouc 7
Ottawa 7
Phoenix 7
Poplar 7
Riyadh 7
Ankara 6
Totale 6.028
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 188
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia 183
Constitutive phosphorylation of the active Notch1 intracellular domain in chronic lymphocytic leukemia cells with NOTCH1 mutation. 180
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment. 173
Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction 158
Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo. 155
Engineering donor mesenchymal cells with IL-7 hastens naive T cell recruitment in vitro and supports immunologic reconstitution after HSCT in NOD/SCID mice 146
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia 139
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL 138
Graft engineering for allogeneic haploidentical stem cell transplantation 137
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia 134
GATA1 epigenetic deregulation contributes to the development of AML with NPM1 and FLT3-ITD cooperating mutations 132
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia. 131
Mesenchymal cells: a vehicle for gene therapy 127
"Designed" grafts for HLA-haploidentical stem cell transplantation. 126
NPM1 AND FLT3-ITD MUTATIONS SINERGISTICALLY INDUCE GATA1 EPIGENETIC SILENCING IN A AML MOUSE MODEL 126
In Vivo Real Time Monitoring of Stem Cells Homing in Postischemic Tissues 126
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 125
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 124
γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and Notch down-regulation. 122
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 122
Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone.Di Ianni M, Moretti L, Del Papa B, De Ioanni M, Bonifacio E, Falzetti F, Tabilio A. 122
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 121
A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. 121
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 121
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 120
Engineering mesenchymal cells with interleukin 7 gene: effects on T cell. 18-23. 119
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 119
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 118
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells. 118
IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation. 116
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 115
IN VIVO DIRECT MONITORING OF STEM CELLS HOMING IN POSTISCHEMIC TISSUES 115
T regulatory cell separation for clinical application. 113
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome 110
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 110
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 110
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 110
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 109
NPM1 AND FLT3-ITD MUTATIONS COOPERATE TO IMPAIR HEMATOPOIETIC STEM/PROGENITOR CELLS DIFFERENTIATION AND DEREGULATE GATA1 IN A MOUSE MODEL OF AML 109
A novel NOTCH1 PEST domain mutation in a case of Chronic Lymphocytic Leukemia 107
Interleukin-7-engineered mesenchymal cells: in vitro effects on naive T-cell population. 106
. Mismatched hematopoietic stem cell transplants in elderly patients. 105
A microelectronic DNA chip detects the V617F JAK-2 mutation in myeloproliferative disorders 103
IN VITRO AND IN VIVO ANTILEUKEMIC ACTIVITY OF BEPRIDIL IN CHRONIC LYMPHOCYTIC LEUKEMIA IS ASSOCIATED WITH INHIBITION OF THE NOTCH1 PATHWAY 100
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 99
The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model. 99
Stem cell mobilization in normal donors. 98
Nephrotic syndrome in primary myelofibrosis with renal extramedullary hematopoiesis and glomerulopathy in the JAK inhibitor era 98
Effetto della severità dell'ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicroscopia 98
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 98
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 98
NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL. 96
BEPRIDIL IS A POTENT NOTCH1 INHIBITOR AND EFFICIENTLY INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) CELLS in vitro AND in vivo 95
MYB deregulation from a EWSR1-MYB fusion at leukemic evolution of a JAK2 V617F positive primary myelofibrosis 94
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 94
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 93
Mismatched hematopoietic stem cell transplantation in secondary leukemia 93
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 92
Novel targets for endoplasmic reticulum stress-induced apoptosis in B-CLL. 92
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 91
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 91
Effetto della severità dell’ischemia sul reclutamento delle cellule staminali nei tessuti postischemici: monitoraggio diretto in vivo mediante videomicrosopia. 90
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 89
Gefitinib enhances the effects of combined radiotherapy and 5-fluorouracil in a colorectal cancer cell line. 89
NOTCH and NF-κB interplay in chronic lymphocytic leukemia is independent of genetic lesion. 89
New mechanism of lymphoma-induced bone marrow aplasia 89
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 86
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 85
Reclutamento delle cellule staminali nei tessuti postischemici: valutazione diretta in vivo mediante videomicroscopia 85
Mesenchymal cells recruit and regulate T regulatory cells. 85
Identification and Characterization of Novel Rare Nucleophosmin (NPM1) Gene Mutations in Acute Myeloid Leukemia (AML) By a Combinatorial Approach of Immunohistochemistry and Molecular Analyses 84
Full haplotype mismatched transplant in high risk acute leukemia patients. 82
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 81
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 79
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 79
Homing and survival of thymidine kinase-transduced human T cells in NOD/SCID mice 78
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 77
Distribution of active alpha and beta subunit of beta-N-acetylhexosaminidase as a function of leukaemic cell types 76
MOLECULAR AND BIOLOGICAL BASIS OF THE ASOCIATION OF RADIOTHERAPY, 5-FLUOROURACIL AND GEFITINIB IN RECTAL CANCER 75
NOTCH1 Aberrant Activation Is a Common Nonmutational Early Event in Chronic Lymphocytic Leukemia Hematopoietic Stem-Cells 75
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 74
Trapianto di cellule staminali nei tessuti post-ischemici: studio in vivo degli effetti delle cellule staminali sulla funzione microvascolare. 72
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 71
THE BRAF INHIBITOR VEMURAFENIB IS SAFE AND HIGHLY EFFECTIVE IN REFRACTORY AND RELAPSED HAIRY CELL LEUKEMIA: RESULTS OF THE HCL-PG01 PHASE-2 ITALIAN CLINICAL TRIAL 70
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 68
Next generation HLA-haploidentical HSCT 68
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 67
NOTCH and Graft-Versus-Host Disease 66
Radioimmunotherapy with 90Y-ibritumomab tiuxetan to treat follicular non Hodgkin-lymphoma in relapse after autologous transplant or refractory to chemotherapy: preliminary results. 61
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 59
Homing and survival of thimidine kinase transduced human T-cells in NOD/SCID mice. 55
Uno strano caso di “eritema pernio” delle mani 54
null 37
Totale 9.723
Categoria #
all - tutte 42.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.975


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022956 0 252 18 43 22 10 14 223 12 77 138 147
2022/20231.471 89 275 15 129 119 150 0 61 558 6 49 20
2023/2024746 30 69 37 29 3 20 178 9 46 38 128 159
2024/20251.523 60 141 60 76 198 52 91 98 260 85 255 147
2025/20263.145 220 201 166 411 464 322 511 143 316 296 62 33
2026/2027135 66 69 0 0 0 0 0 0 0 0 0 0
Totale 9.723